Skip to main content

Table 1 /Baseline demographics in patients undergoing elective coronary procedures

From: Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures

Characteristic No CI-AKI CI-AKI CI-AKI (S1) CI-AKI (S2) P value
Number of subject 114 16 13 3  
CKD stage III: CKD stage IV 90:24 10:6 9:4 1:2  
Age (yr) 70 ± 10 72 ± 7 73 ± 5 70 ± 9 0.67
Men: women 88:26 12:4 10:3 2:1 0.17
SBP (mmHg) 129 ± 17 125 ± 13 125 ± 14 124 ± 14 0.65
DBP(mmHg) 71 ± 10 69 ± 12 70 ± 12 67 ± 8 0.74
Heart rate 75 ± 10 74 ± 12 76 ± 11 72 ± 8 0.48
Height (cm) 162 ± 9 161 ± 9 160 ± 7 162 ± 8 0.85
Weight (kg) 60 ± 13 56 ± 7 58 ± 5 54 ± 8 0.16
Body mass index (kg/m2) 24 ± 4 23 ± 3 23 ± 3 21 ± 4 0.14
Diabetes mellitus (%) 42 44 46 33 0.25
Hypertension (%) 80 75 77 67 0.19
Hypercholesterolemia (%) 50 44 38 67 0.16
Myocardial infarction (%) 18 25 23 33 0.37
LVEF < 40% (%) 20 19 15 33 0.59
CCS > II (%) 96 94 92 100 0.49
NYHA > II (%) 44 44 38 67 0.6
Angiogram/PCI (%) 66 75 85 67 0.58
Number of vessel disease > 1 (%) 61 63 50 67 0.62
ACEI (%) 30 31 31 33 0.42
ATRA (%) 40 31 31 33 0.48
Beta blocker (%) 54 44 38 67 0.56
CCB (%) 28 31 31 33 0.26
Diuretic (%) 26 31 31 33 0.64
Aspirin (%) 72 63 62 67 0.51
Statin (%) 48 44 38 67 0.17
Nitrate (%) 38 38 31 67 0.14
Contrast volume (ml) 126 ± 65 129 ± 90 126 ± 80 124 ± 92 0.43
IV volume (ml) 1483 ± 453 1591 ± 260 1598 ± 246 1562 ± 128 0.48
Total risk score 8 ± 3 8 ± 3 8 ± 3 9 ± 1 0.24
  1. CI-AKI indicates contrast induced acute kidney injury, CI-AKI (S1) indicates CI-AKI stage I, CI-AKI (S2) indicates CI-AKI stage II, SBP indicates systolic blood pressure, DBP indicates diastolic blood pressure, LVEF indicates left ventricular ejection fraction, CCS indicates Canadian Cardiovascular Society, NYHA indicates New York Heart Association, PCI indicates percutaneous intervention, CCB indicates calcium channel blocker.